Each ml contains 1.5mg Meloxicam.
Melox is a COX-2-selective NSAID with analgesic, anti-inflammatory, and antipyretic properties.
It is indicated for the management of acute and chronic inflammation associated with musculoskeletal conditions (e.g., osteoarthritis) and for the alleviation of postoperative pain.
Dogs:
- Initial dose: 0.2 mg/kg on the first day
- Subsequent doses: 0.1 mg/kg once daily for 3–4 days
Cats (extra-label):
- Standard dose: 0.05 mg/kg once daily for 4 days
- Maintenance dose: 0.01–0.05 mg/kg once daily
- Do not use in pregnant or lactating animals.
- Do not use in dogs with gastrointestinal disorders, or with impaired hepatic, cardiac, or renal function, or haemorrhagic disorders.
- Do not use in cases of hypersensitivity to the active substance or any excipients.
- Do not use in dogs under 6 weeks of age.
Special Precautions
- Avoid use in dehydrated, hypovolaemic, or hypotensive animals, as there is a potential risk of renal toxicity.
Side Effects
- Rare adverse reactions associated with NSAIDs may include vomiting, diarrhoea, faecal occult blood, haematemesis, gastrointestinal ulceration, and elevated liver enzymes.
- These side effects are generally transient and occur within the first week of treatment.
- In cases of overdose, symptomatic treatment should be initiated.
Peterson, Kurt D. “Effects of Meloxicam on Severity of Lameness and Other Clinical Signs of Osteoarthritis in Dogs.” Journal of the American Veterinary Medical Association 225, no. 7 (2004): 1056-1060. https://doi.org/10.2460/javma.2004.225.1056
Taylor, Samantha. “2024 ISFM and AAFP Consensus Guidelines on the Long-Term Use of NSAIDs in Cats.” Journal of Feline Medicine and Surgery 26, no. 4 (2024): 1-23. https://doi.org/10.1177/1098612x241241951
